DXCM · 10-Q · 2026Q3 · Full report

Strategic Initiatives

DEXCOM INC · 2026-10-29 · Importance 20 · Surprise 24

Dexcom plans to develop future generations of technologies focused on improved performance and convenience, including capabilities for intelligent insulin administration. Over the longer term, it plans to improve networked platforms with open architecture and connectivity, and use predictive modeling and machine learning to generate CGM insights. The company continues partnerships with insulin-pump and automated-insulin-delivery developers and is pursuing consumer-technology partnerships following Stelo’s introduction. It is also exploring offerings for people with prediabetes, obesity, pregnancy, and hospital patients.

Key facts

• Dexcom plans to develop future technology generations focused on improved performance and convenience that enable intelligent insulin administration. source
• Over the longer term, Dexcom plans to develop and improve networked platforms with open architecture, connectivity, and transmitters capable of communicating with other devices. source
• Dexcom intends to expand efforts to accumulate CGM patient data and metrics and use predictive modeling and machine learning to generate interactive CGM insights. source
• Dexcom supports partnerships with insulin pump companies and companies or institutions developing insulin delivery systems, including automated insulin delivery systems. source
• Following Stelo's introduction, Dexcom is pursuing and supporting development partnerships with consumer technology product companies seeking to provide metabolic health insights to their customers. source
• Dexcom is exploring opportunities for people with pre-diabetes, people who are obese, people who are pregnant, and people in hospital settings. source